23andMe shares slide more than 15% as lower services revenue hits Q3 results

Shares of 23andMe Holding Co. fell 15.8% Thursday after the DNA-testing company fiscal third-quarter sales declined 33%, weighed down by lower consumer services and research revenue.

Previous post ‘I’m dipping into my Roth IRA’: I’ve been unemployed for 5 months. I used to earn $10,000 a month. Do I sell my house?
Next post Arm’s stock explodes 50% higher as company proves itself an early AI winner